GENE ONLINE|News &
Opinion
Blog

Regulatory
Trials & Approvals Rare Disease
FDA Okays Expensive Gene Therapy for Infantile-Onset Spinal Muscular Atrophy
2019-05-29
Trials & Approvals CDK4/6
Kisqali Fulvestrant Combo Rejected by NICE for Breast Cancer Treatment in the UK
2019-05-02
Trials & Approvals EGFR
Erdafitinib Approval,a Bright Spot Amid the Troughs in Bladder Cancer Trials
2019-04-23
Trials & Approvals EGFR
Vizimpro bags EU approval for NSCLC treatment
2019-04-16
Trials & Approvals Anxiety
FDA Approves New Drug for Specific Treatment of Postpartum Depression
2019-03-21
Trials & Approvals Breast Cancer
Tecentriq/Arbaxane Combo Becomes the First FDA Approved Immunotherapy Regimen for Breast Cancer Treatment
2019-03-14
Trials & Approvals Breast Cancer
Herceptin Hylecta bags FDA approval for HER2-Positive Breast Cancer Treatment
2019-03-04
Trials & Approvals Ovarian Cancer
First PARP inhibitor approved for 1L maintenance therapy of BRCAm advanced ovarian cancer
2018-12-28
Trials & Approvals Antibody
Tecentriq bags yet another FDA approval, this time as a combo therapy for NSCLC
2018-12-24
Trials & Approvals
Roche Announces Analysis of Hemlibra’s Phase III HAVEN 2 Study at ASH meeting
2018-12-21
Trials & Approvals
European approval of Pembrolizumab for resected Stage III melanoma – KN-54 excerpts
2018-12-21
Trials & Approvals Autoimmune
Novartis’s Ligelizumab Progresses to Phase III Trial
2018-12-17
Trials & Approvals Alanine Aminotransferase
Expedited Approval of Vitrakvi® Marks Many Firsts in Cancer Therapy
2018-12-04
Trials & Approvals Hepatocellular Carcinoma
New hepatocellular carcinoma approval for Pembrolizumab – KN-224
2018-11-14
Trials & Approvals Multiple Myeloma
Empliciti®(elotuzumab) combination – New IO approval for relapsed Multiple Myeloma
2018-11-09
1 … 50 51 52 53
LATEST
First Person to Receive Transplanted Pig Kidney has Died
2024-05-13
Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for Injection (Albumin Bound)
2024-05-10
Biotech in Beauty: Engineered Skin Bacteria Designed To Treat Acne
2024-05-10
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Infinitopes’ Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
2024-05-09
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top